These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 16728930

  • 21. Autoimmunity in thrombotic thrombocytopenic purpura.
    Porta C, Caporali R, Montecucco C.
    Semin Thromb Hemost; 2005 Dec; 31(6):633-40. PubMed ID: 16388414
    [Abstract] [Full Text] [Related]

  • 22. [Refractory thrombotic thrombocytopenic purpura successfully treated with a combination of rituximab and vincristine].
    Kaneko H, Matsumoto M, Okamoto K, Chyonabayashi K, Hishizawa M, Watanabe M, Fujimura Y, Tsudo M.
    Rinsho Ketsueki; 2007 Feb; 48(2):144-7. PubMed ID: 17370643
    [Abstract] [Full Text] [Related]

  • 23. Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura.
    Kosugi S, Matsumoto M, Ohtani Y, Take H, Ishizashi H, Fujimura Y, Kuyama J.
    Int J Hematol; 2005 Jun; 81(5):433-6. PubMed ID: 16158827
    [Abstract] [Full Text] [Related]

  • 24. [Recent therapeutic strategy for thrombotic thrombocytopenic purpura].
    Fujimura Y, Matsumoto M, Isonishi A, Yagi H, Kokame K, Miyata T.
    Rinsho Ketsueki; 2014 Jan; 55(1):93-104. PubMed ID: 24492042
    [No Abstract] [Full Text] [Related]

  • 25. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).
    Ahmad A, Aggarwal A, Sharma D, Dave HP, Kinsella V, Rick ME, Schechter GP.
    Am J Hematol; 2004 Oct; 77(2):171-6. PubMed ID: 15389904
    [Abstract] [Full Text] [Related]

  • 26. Rituximab in a child with autoimmune thrombotic thrombocytopenic purpura refractory to plasma exchange.
    Narayanan P, Jayaraman A, Rustagi RS, Mahadevan S, Parameswaran S.
    Int J Hematol; 2012 Jul; 96(1):122-4. PubMed ID: 22552883
    [Abstract] [Full Text] [Related]

  • 27. Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus.
    Kamiya K, Kurasawa K, Arai S, Maezawa R, Hanaoka R, Kumano K, Fukuda T.
    Mod Rheumatol; 2010 Feb; 20(1):81-5. PubMed ID: 19784542
    [Abstract] [Full Text] [Related]

  • 28. [Successful treatment of thrombotic thrombocytopenic purpura (TTP) with rituximab].
    Arici B, Trendelenburg M.
    Ther Umsch; 2008 Dec; 65(12):710-2. PubMed ID: 19048526
    [Abstract] [Full Text] [Related]

  • 29. Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature.
    Yomtovian R, Niklinski W, Silver B, Sarode R, Tsai HM.
    Br J Haematol; 2004 Mar; 124(6):787-95. PubMed ID: 15009067
    [Abstract] [Full Text] [Related]

  • 30. Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab.
    Caramazza D, Quintini G, Abbene I, Malato A, Saccullo G, Lo Coco L, Di Trapani R, Palazzolo R, Barone R, Mazzola G, Rizzo S, Ragonese P, Aridon P, Abbadessa V, Siragusa S.
    Transfusion; 2010 Dec; 50(12):2753-60. PubMed ID: 20576013
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Refractory thrombotic thrombocytopenic purpura in a 16-year-old girl: successful treatment with bortezomib.
    van Balen T, Schreuder MF, de Jong H, van de Kar NC.
    Eur J Haematol; 2014 Jan; 92(1):80-2. PubMed ID: 24118335
    [Abstract] [Full Text] [Related]

  • 33. Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assays.
    McDonald V, Liesner R, Grainger J, Gattens M, Machin SJ, Scully M.
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):245-50. PubMed ID: 20083997
    [Abstract] [Full Text] [Related]

  • 34. The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine.
    Böhm M, Betz C, Miesbach W, Krause M, von Auer C, Geiger H, Scharrer I.
    Br J Haematol; 2005 Jun; 129(5):644-52. PubMed ID: 15916687
    [Abstract] [Full Text] [Related]

  • 35. [Rituximab provided long-term remission in a patient with severe thrombotic thrombocytopenic purpura refractory to plasma exchange].
    Hong H, Aoyama Y, Yamamura R, Ohta T, Mugitani A, Yamane T, Hino M, Matsumoto M, Fujimura Y.
    Rinsho Ketsueki; 2006 Dec; 47(12):1528-32. PubMed ID: 17233471
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Targeting the inhibitor of ADAMTS13 in thrombotic thrombocytopenic purpura.
    Cataland SR, Wu HM.
    Expert Opin Pharmacother; 2007 Mar; 8(4):437-44. PubMed ID: 17309338
    [Abstract] [Full Text] [Related]

  • 38. [Treatment of thrombotic thrombocytopenic purpura].
    Ueda Y.
    Rinsho Ketsueki; 2014 Oct; 55(10):2076-86. PubMed ID: 25297774
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Rituximab therapy for refractory thrombotic thrombocytopenic purpura.
    Gutterman LA, Kloster B, Tsai HM.
    Blood Cells Mol Dis; 2002 Oct; 28(3):385-91. PubMed ID: 12367582
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.